D. Koychev

Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update.

C. Bokemeyer, K. Oechsle, F. Honecker, 2011, International journal of andrology.

Fractionated Irradiation Can Induce Functionally Relevant Multidrug Resistance Gene and Protein Expression in Human Tumor Cell Lines

E. Thiel, T. Wiegel, D. Bottke, 2005, Radiation research.

ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines

W. Hopfenmüller, W. Hopfenmüller, M. Zeitz, 2009, Neuroendocrinology.

ZM 447439, a novel promising aurora kinase inhibitor, provoking antiproliferative and pro-apoptotic effects alone and in combination with bio- and chemotherapeutic agents in gastroenteropancreatic neuroendocrine tumor disease

M. Zeitz, J. Holstein, P. Grabowski, 2007 .

Venous Thromboembolic Events in Germ Cell Cancer Patients Undergoing Platinum-Based Chemotherapy

C. Bokemeyer, K. Oechsle, K. Dieckmann, 2013, Oncology Research and Treatment.

Pertuzumab as second‑ or later‑line therapy for human epidermal growth factor receptor 2‑positive metastatic breast cancer: A clinical experience

C. Leo, E. Biskup, M. Vetter, 2021, Molecular and clinical oncology.

ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines

W. Hopfenmüller, M. Zeitz, J. Holstein, 2009, Neuroendocrinology.